Clinical Trial Update: Single Ascending Dose Study of NH102 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study of NH102 conducted in healthy subjects has completed. The trial focused on safety, with Depression listed as the condition o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NH102

Snippet

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. | Conditions: Depression | Phase 1 | Status: COMPLETED